2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Cardiotoxicity
7
Lymphoma, Non-Hodgkin
5
Breast Neoplasms
5
Neoplasms
4
Lymphoma
4
Prostatic Neoplasms
3
Myelodysplastic Syndromes
3
Lung Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Heart Failure
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Dyslipidemias
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Ventricular Dysfunction, Left
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Interventions
Metformin
7
Testosterone
2
Pioglitazone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Electrocardiography
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled